Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$168K Hold
40,872
2.54% 7
2019
Q2
$188K Buy
40,872
+5,240
+15% +$401K 3.49% 6
2019
Q1
$43K Sell
35,632
-71,369
-67% -$5.34M 0.6% 10
2018
Q4
$348K Buy
107,001
+19,912
+23% +$1.41M 1.28% 25
2018
Q3
$50K Buy
87,089
+15,720
+22% +$1M 0.08% 148
2018
Q2
$47K Sell
71,369
-144,624
-67% -$8.16M 0.07% 170
2018
Q1
$303K Buy
215,993
+31,440
+17% +$1.7M 0.21% 105
2017
Q4
$279K Buy
184,553
+39,929
+28% +$2.21M 0.19% 63
2017
Q3
$113K Buy
+144,624
New +$8.77M 0.07% 221

Other funds holding MRK

TLP Group's MRK Position: Q3 2019 in Review

TLP Group sold out of Merck (MRK) in Q3 2019, closing a stake of 276,462 shares — an estimated $22.2M sold.

TLP Group first reported a position in MRK in Q4 2015 and held it in 12 quarters. The position peaked at $2.33M in Q4 2017. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • TLP Group reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • TLP Group sold 276,462 Merck shares in Q3 2019, an estimated $22.2M.
  • TLP Group first reported a position in Merck in Q4 2015 and held it in 12 quarters.
  • TLP Group's Merck position peaked at $2.33M in Q4 2017.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on TLP Group's 13F filing for Q3 2019, filed 11 Oct 2019.